Literature DB >> 214688

Protection of guinea pigs against primary and recurrent genital herpes infections by immunization with live heterologous or homologous Herpes simplex virus: implications for a herpes virus vaccine.

M Scriba.   

Abstract

Guinea pigs, inoculated intravaginally with HSV type 2 develop a primary and spontaneously recurring genital herpes with clinical symptoms resembling genital herpes in humans. The effect of a previous infection with either HSV type 1 or HSV type 2 on the clinical course of the intravaginal challenge infection was studied. Prior infection with either subtype of HSV moderated considerably the acute disease induced by intravaginal HSV type 2 challenge. No effect was, however, observed on the development of the chronic phase of the challenge infection. The significance of these studies for the possibility of vaccination against recurrent herpes infections is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214688     DOI: 10.1007/bf02121135

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  9 in total

1.  Reactions of autoinoculation for recurrent herpes simplex.

Authors:  L GOLDMAN
Journal:  Arch Dermatol       Date:  1961-12

2.  Vaccination for recurrent herpes simplex infection; initiation of a new disease site following the use of unmodified material containing the live virus.

Authors:  M P LAZAR
Journal:  AMA Arch Derm       Date:  1956-01

3.  Herpes simplex virus infection in guinea pigs: an animal model for studying latent and recurrent herpes simplex virus infection.

Authors:  M Scriba
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

4.  Extraneural localisation of herpes simplex virus in latently infected guinea pigs.

Authors:  M Scriba
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

5.  Recurrent genital Herpes simplex virus (HSV) infection of guinea pigs.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1976-12-01       Impact factor: 3.402

6.  Experimental human reinfection with herpes simplex virus.

Authors:  H Blank; H G Haines
Journal:  J Invest Dermatol       Date:  1973-10       Impact factor: 8.551

7.  Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection.

Authors:  M L Cook; J G Stevens
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

8.  Hepres genitalis; clinical and cytopathologic experience with 256 patients.

Authors:  A B Ng; J W Reagan; S S Yen
Journal:  Obstet Gynecol       Date:  1970-10       Impact factor: 7.661

9.  Antibodies to Herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections.

Authors:  A J Nahmias; W E Josey; Z M Naib; C F Luce; A Duffey
Journal:  Am J Epidemiol       Date:  1970-06       Impact factor: 4.897

  9 in total
  8 in total

1.  Protective effect of an oral infection with herpes simplex virus type 1 against subsequent genital infection with herpes simplex virus type 2.

Authors:  B Sturn; K E Schneweis
Journal:  Med Microbiol Immunol       Date:  1978-07-04       Impact factor: 3.402

2.  Criteria for development of animal models of diseases of the reproductive system.

Authors:  L B Corbeil
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

Review 3.  Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?

Authors:  Gargi Dasgupta; Lbachir BenMohamed
Journal:  Vaccine       Date:  2011-06-28       Impact factor: 3.641

Review 4.  The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine.

Authors:  Tiffany Kuo; Christine Wang; Tina Badakhshan; Sravya Chilukuri; Lbachir BenMohamed
Journal:  Vaccine       Date:  2014-10-16       Impact factor: 3.641

Review 5.  New concepts in herpes simplex virus vaccine development: notes from the battlefield.

Authors:  Gargi Dasgupta; Aziz A Chentoufi; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  Expert Rev Vaccines       Date:  2009-08       Impact factor: 5.217

6.  Pathogenicity of wild-type and temperature-sensitive mutants of herpes simplex virus type 2 in guinea pigs.

Authors:  C A Anderson; M J August; G D Hsiung
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

7.  Animal studies on the efficacy of vaccination against recurrent herpes.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

8.  Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice.

Authors:  R J Klein; E Buimovici-Klein; H Moser; R Moucha; J Hilfenhaus
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.